WallStreetZenWallStreetZen

NASDAQ: DERM
Journey Medical Corp Stock

$2.00-0.05 (-2.44%)
Updated Jan 27, 2023
DERM Price
$2.00
Fair Value Price
N/A
Market Cap
$35.41M
52 Week Low
$1.05
52 Week High
$5.95
P/E
-0.67x
P/B
1.35x
P/S
0.58x
PEG
N/A
Dividend Yield
N/A
Revenue
$75.22M
Earnings
-$40.74M
Gross Margin
56.7%
Operating Margin
-35.7%
Profit Margin
-54.2%
Debt to Equity
3.13
Operating Cash Flow
-$13M
Beta
0.46
Next Earnings
Mar 22, 2023
Ex-Dividend
N/A
Next Dividend
N/A

DERM Overview

Journey Medical Corporation develops and commercializes pharmaceuticals to treat dermatological conditions in the U.S. Products include Qbrexza, Accutane, Targadox, Ximino, and Exelderm. Journey Medical also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. Formerly known as Coronado Dermatology, Inc., the company was incorporated in 2014 and is headquartered in Scottsdale, AZ.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DERM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DERM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DERM is good value based on its book value relative to its share price (1.35x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.9x)
P/B vs Industry Valuation
DERM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more DERM due diligence checks available for Premium users.

Be the first to know about important DERM news, forecast changes, insider trades & much more!

DERM News

Valuation

DERM fair value

Fair Value of DERM stock based on Discounted Cash Flow (DCF)
Price
$2.00
Fair Value
$3.83
Undervalued by
47.79%
DERM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

DERM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.67x
Industry
20.07x
Market
23.59x

DERM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.35x
Industry
1.9x
DERM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DERM's financial health

Profit margin

Revenue
$16.1M
Net Income
-$10.1M
Profit Margin
-62.5%
DERM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DERM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$108.1M
Liabilities
$82.0M
Debt to equity
3.13
DERM's short-term assets ($79.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DERM's short-term assets ($79.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DERM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.3M
Investing
$0.0
Financing
$4.0M
DERM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

DERM vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
DERM$35.41M-2.44%-0.67x1.35x
HUGE$36.32M-1.75%-2.21x1.38x
MDVL$38.18M-3.25%-0.43x1.22x
CPIX$39.49M-0.18%-5.81x1.02x
ZYNE$31.20M+4.57%-0.76x0.59x

Journey Medical Stock FAQ

What is Journey Medical's quote symbol?

NASDAQ: DERM) Journey Medical trades on the NASDAQ under the ticker symbol DERM. Journey Medical stock quotes can also be displayed as NASDAQ: DERM.

If you're new to stock investing, here's how to buy Journey Medical stock.

What is the 52 week high and low for Journey Medical (NASDAQ: DERM)?

(NASDAQ: DERM) Journey Medical's 52-week high was $5.95, and its 52-week low was $1.05. It is currently -66.39% from its 52-week high and 90.48% from its 52-week low.

How much is Journey Medical stock worth today?

(NASDAQ: DERM) Journey Medical currently has 17,704,325 outstanding shares. With Journey Medical stock trading at $2.00 per share, the total value of Journey Medical stock (market capitalization) is $35.41M.

Journey Medical stock was originally listed at a price of $9.50 in Nov 12, 2021. If you had invested in Journey Medical stock at $9.50, your return over the last 1 years would have been -78.95%, for an annualized return of -78.95% (not including any dividends or dividend reinvestments).

How much is Journey Medical's stock price per share?

(NASDAQ: DERM) Journey Medical stock price per share is $2.00 today (as of Jan 27, 2023).

What is Journey Medical's Market Cap?

(NASDAQ: DERM) Journey Medical's market cap is $35.41M, as of Jan 29, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Journey Medical's market cap is calculated by multiplying DERM's current stock price of $2.00 by DERM's total outstanding shares of 17,704,325.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.